Oteseconazole + Rosuvastatin Interaction
Unknowninteraction on record
Description
Concomitant use of VIVJOA with BCRP substrates (e.g., rosuvastatin) may increase the exposure of BCRP substrates (e.g., rosuvastatin), which may increase the risk of adverse reactions associated with these drugs.
Source: FDA drug label - oteseconazole